.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Fresenius Kabi Usa Company Profile

« Back to Dashboard

Summary for Applicant: Fresenius Kabi Usa

Patents:15
Tradenames:163
Ingredients:133
NDAs:207
Drug Master File Entries: (click here to view)52
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
IFOSFAMIDE
ifosfamide
INJECTABLE;INJECTION076078-001May 28, 2002RXYes<disabled><disabled>
Fresenius Kabi Usa
XYLOCAINE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION006488-017Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Fresenius Kabi Usa
XYLOCAINE 4% PRESERVATIVE FREE
lidocaine hydrochloride
INJECTABLE;INJECTION010417-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc